Amoxicillin-Clavulanate Extended-Release Tablets 1000mg/62.5mg from Canada
XR formulation combining amoxicillin and clavulanate for twice-daily dosing in respiratory infections. This mixed penicillin-based antibiotic in measured tablet doses for retail qualifies under HTS 3004.10.50.49 'other combination antibiotics'.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include dissolution profile testing for extended-release verification
• Ensure child-resistant blister packaging for retail compliance
• Monitor for DEA scheduling if combined with controlled substances